Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma

Blood

Volumn 88, Issue 10, 1996, Pages 3815-3823

  Broze Jr , George J ^a   Higuchi, Darryl A ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBIN INHIBITOR; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING FACTOR DEFICIENCY; ENZYME MECHANISM; FIBRINOLYSIS; HEMOPHILIA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 10544253848     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3815.bloodjournal88103815     Document Type: Article

References (38)

1. Broze GJ Jr: Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med 46:103, 1995
2. Naito K, Fujikawa K: Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 266:7353, 1991
3. Gailani D, Broze GJ: Factor XI activation in a revised model of blood coagulation. Science 253:909, 1991
4. Marlar RA, Kleiss AJ, Griffin JH: An alternative extrinsic pathway of human blood coagulation. Blood 60:1353, 1982
5. Biggs R, MacFarlane RG: The reaction of hemophiliac plasma to thromboplastin. J Clin Invest 4:445, 1951
6. Hemker HC, Beguin S: Thrombin generation in plasma: Its assessment via the endogenous thrombin potential. Thromb Haemost 74:134, 1995
7. Walsh PN, Rizza CR, Matthews JM, Eipe J, Kernoff PB, Coles MD, Bloom AL, Kaufman BM, Beck P, Hanan CM, Biggs R: Epsilon-aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: A double-blind controlled trial. Br J Haematol 20:463, 1971
8. Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U: Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coag Fibrinol 3:465, 1992
9. Hendriks D, Wang W, Scharpe S, Lommaert MP, van Sande M: Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim Biophys Acta 1034:86, 1990
10. Hendriks D, Scharpe S, van Sande M, Lommaert MP: Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J Clin Chem Clin Biochem 27:277, 1989
11. Campbell W, Okada H: An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem Biophys Res Commun 162:933, 1989
12. Campbell W, Yonezu K, Shinohara T, Okada H: An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis. J Lab Clin Med 115:610, 1990
13. Eaton DL, Malloy BE, Tsai SP, Henzel W, Drayna D: Isolation, molecular cloning and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 266:21833, 1991
14. Wang W, Hendriks D, Scharpe SS: Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 269:15937, 1994
15. Bajzar L, Manuel R, Nesheim ME: Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor. J Biol Chem 270:14477, 1995
16. Bajzar L, Nesheim M: The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation. J Biol Chem 268:8606, 1993
17. Bajzar L, Nesheim M: Thrombomodulin promotes thrombincatalyzed activation of TAFI (thrombin activatable fibrinolysis inhibitor). Thromb Haemost 73:1129, 1995 (abstr 875)
18. Broze GJ Jr, Majerus PW: Purification and properties of human coagulation factor VII. J Biol Chem 255:1242, 1980
19. Miletich JP, Broze GJ Jr. Majerus PW: Purification of human coagulation factors II, IX, and X using sulfated dextran beads. Methods Enzymol 80:221, 1981
20. Miletich J, Jackson C, Majerus PW: Properties of the factor Xa binding site on human platelets. J Biol Chem 253:6908, 1978
21. Castellino FJ, Powell JR: Human plasminogen. Methods Enzymol 80:365, 1981
22. Parkinson JF, Grinnell BW, Moore RE, Hoskins J, Vlahos CJ, Bang NU: Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem 265:12602, 1990
23. Scott CF, Colman RW: Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate. Proc Natl Acad Sci USA 89:11189, 1992
24. Schweisfurth H, Reinhart E, Heinrich J, Brugger E: A simple spectrometric assay of carboxypeptidase N (kininase I) in human serum. J Clin Chem Clin Biochem 21:605, 1983
25. Broze GJ Jr, Lange GW, Duffin KL, MacPhail L: Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coag Fibrinol 5:551, 1994
26. Hooper NM: Families of zinc metalloproteases. FEBS Lett 354:1, 1994
27. Suenson E, Lutzen O, Thorsen S: Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 140:513, 1984
28. Tran-Thang C, Kruithof EKO, Atkinson J, Bachmann F: High-affinity binding sites for human glu-plasminogen unveiled by limited plasmic degradation of human fibrin. Eur J Biochem 160:599, 1986
29. Fleury V, Angles-Cano E: Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines. Biochemistry 30:7630, 1991
30. Plummer TH Jr, Hurwitz MY: Human plasma carboxypeptidase N: Isolation and characterization. J Biol Chem 253:3907, 1978
31. Levin Y, Skidgel RA, Erdos EG: Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase I). Proc Natl Acad Sci USA 79:4618, 1982
32. de Fouw NJ, van Tilburg NH, Haverkate F, Bertina RM: Activated protein C accelerates clot lysis by virtue of its anticoagulant activity. Blood Coag Fibrinol 4:201, 1993
33. von dem Borne PAK, Meijers JCM, Bouma BN: Feedback activation of factor XI by thrombin in plasma results in formation of additional thrombin that protects fibrin clots from fibrinolysis. Blood 86:3035, 1995
34. Esmon CT: The protein C anticoagulant pathway. Arterioscler Thromb 12:135, 1992
35. Redlitz A, Tan AK, Eaton DL, Plow EF: Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest 96:2534, 1995
36. Erhardtsen E, Ezban M, Madsen MT, Diness V, Glazer S, Hedner U: Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coag Fibrinol 6:388, 1995
37. Hedner U, Glazer S, Falch J: Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. Transfus Med Rev 7:78, 1993
38. O'Brien DP, Giles AR, Tate KM, Vehar GA: Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model. J Clin Invest 82:206, 1988